NDC 67544-142

Lorazepam

Lorazepam

Lorazepam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Lorazepam.

Product ID67544-142_cb8a79d2-86b3-4746-bd69-40105a3c0451
NDC67544-142
Product TypeHuman Prescription Drug
Proprietary NameLorazepam
Generic NameLorazepam
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1991-10-31
Marketing CategoryANDA / ANDA
Application NumberANDA072928
Labeler NameAphena Pharma Solutions - Tennessee, LLC
Substance NameLORAZEPAM
Active Ingredient Strength2 mg/1
Pharm ClassesBenzodiazepine [EPC],Benzodiazepines [CS]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 67544-142-15

15 TABLET in 1 BOTTLE, PLASTIC (67544-142-15)
Marketing Start Date2012-12-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67544-142-53 [67544014253]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-12-11

NDC 67544-142-30 [67544014230]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-03-25

NDC 67544-142-60 [67544014260]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-12-12

NDC 67544-142-70 [67544014270]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-12-15

NDC 67544-142-45 [67544014245]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-03-25

NDC 67544-142-15 [67544014215]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-12-27

Drug Details

Active Ingredients

IngredientStrength
LORAZEPAM2 mg/1

OpenFDA Data

SPL SET ID:4b1bde7b-1e2a-4e31-92ad-71380034ff82
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197900
  • 197901
  • 197902

    • Pharmacological Class

    • Benzodiazepine [EPC]
    • Benzodiazepines [CS]
    • Benzodiazepine [EPC]
    • Benzodiazepines [CS]

    NDC Crossover Matching brand name "Lorazepam" or generic name "Lorazepam"

    NDCBrand NameGeneric Name
    0054-3532LorazepamLorazepam
    0093-3425LorazepamLorazepam
    0093-3426LorazepamLorazepam
    0093-3427LorazepamLorazepam
    0121-0770LorazepamLorazepam
    67544-982LorazepamLorazepam
    0409-6779LorazepamLorazepam
    0409-6778LorazepamLorazepam
    0409-6780LorazepamLorazepam
    68071-3010LorazepamLorazepam
    68071-3227LorazepamLorazepam
    68071-3121LorazepamLorazepam
    68071-3242LorazepamLorazepam
    68071-3096LorazepamLorazepam
    68084-736LorazepamLorazepam
    68084-742LorazepamLorazepam
    68084-754LorazepamLorazepam
    68788-0241LorazepamLorazepam
    68788-9511LorazepamLorazepam
    68788-7355LorazepamLorazepam
    68788-7411LorazepamLorazepam
    68788-9839LorazepamLorazepam
    68788-9258LorazepamLorazepam
    68788-9840LorazepamLorazepam
    68788-9982LorazepamLorazepam
    69315-904LorazepamLorazepam
    69315-906LorazepamLorazepam
    69315-905LorazepamLorazepam
    0591-0240LorazepamLorazepam
    0591-0241LorazepamLorazepam
    0591-0242LorazepamLorazepam
    70518-0155LorazepamLorazepam
    70518-0486LorazepamLorazepam
    70518-0275LorazepamLorazepam
    70518-0156LorazepamLorazepam
    70518-0445LorazepamLorazepam
    70518-1045LorazepamLorazepam
    70518-1431LorazepamLorazepam
    70518-1520LorazepamLorazepam
    70518-1313LorazepamLorazepam
    70518-1679LorazepamLorazepam
    70518-1255LorazepamLorazepam
    0603-4246LorazepamLorazepam
    71205-200LorazepamLorazepam
    71205-235LorazepamLorazepam
    71205-228LorazepamLorazepam
    71205-166LorazepamLorazepam
    71335-0277LorazepamLorazepam
    71335-0655LorazepamLorazepam
    71335-0204LorazepamLorazepam
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.